IL22 and graft versus host disease: As compared with 1-DEX-treated Gut-aGVHD or non-GVHD recipients, 4-DEX-treated SR-Gut-aGVHD recipients had a marked increase in bacterial colony formation, and IL-22 deficiency in donor T cells prevented this effect (Fig. 3e).